Accolade

Accolade EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Accolade (ACCD) as of Nov 4, 2026 is -14.52 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 15.05 % — a change of -196.50% (lower).

EBIT/Assets

-14.52 %

YoY

-196.50%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Accolade is 2024 -14.52 % . Operating Income to Assets Ratio (EBIT/Assets) of Accolade was 2023 15.05 % . It decreases by -196.50% lower compared to the previous year.

The Accolade EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-126.35 USD
Jan 1, 2019
-82.22 USD
Jan 1, 2020
-38.83 USD
Jan 1, 2021
-9.87 USD
Jan 1, 2022
-13.31 USD
Jan 1, 2023
15.05 USD
Jan 1, 2024
-14.52 USD
The Accolade EBIT/Assets history
YEAREBIT/AssetsYoY
-14.52 %-196.50%
15.05 %-213.04%
-13.31 %+34.91%
-9.87 %-74.59%
-38.83 %-52.77%
-82.22 %-34.93%
-126.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accolade Stock analysis

What does Accolade do? Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accolade stock

Operating Income to Assets Ratio (EBIT/Assets) of Accolade is -14.52 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Accolade changed from 15.05 % to -14.52 %, representing a -196.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Accolade since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Accolade with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Accolade

All Key Metrics — Accolade